Virtus LifeSci Biotech Clinical Trials ETF

Virtus LifeSci Biotech Clinical Trials ETF
  • Pininvest Analysis

About - Virtus Investment Partners VRTS/NASDAQ is a premier provider of investment solutions to individuals, financial advisors, and institutions. We aim to offer distinguished strategies and original perspectives to help our clients achieve better outcomes

Virtus ETF Solutions is an industry leader in subadvised exchange traded funds

Virtus LifeSci Biotech Clinical Trials ETF  BBC/NYSEARCA invests in clinical trials stage biotechnology companies. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drug candidates in human clinical trials

LifeSci Index Partners, LLC is a New York-based index provider of healthcare-based stock market indices. The LifeSci team is comprised of investment professionals with experience in biotechnology equity research, in organic chemistry research in academia, and at pharmaceutical and biotechnology companies

Note from DATAvariance
The complete list of the 83 BBC constituents on the theme are not weighted; performance and volatility are calculated for informative purpose only - assuming one share of each component had been invested at the beginning of the selected period

For actual performance of the fund, which maybe higher or lower, depending on the weighting and trades decided by the provider, please check the information available on the Virtus LifeSci Clinical Trials ETF site or contact your advisor

More about Virtus LifeSci Biotech Clinical Trials ETF

Virtus LifeSci Biotech Clinical Trials ETF • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Vol. Risk Contrib. MDD
 
Abeona Therapeutics ABEO NASDAQ Health Care Biopharmaceuticals USD 2.97 146 M -79.3% 97%   0% -89%
Acceleron Pharma XLRN NASDAQ Health Care Biopharmaceuticals USD 43.90 2.3 B -15.6% 45%   1% -36%
Achaogen Inc AKAO NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 0.11 7.0 M -97.5% 151%   0% -98%
Achillion Pharmaceuticals ACHN NASDAQ Health Care Drug Manufacturers - Diversified USD 3.93 549 M 23.2% 79%   3% -66%
Aduro Biotech ADRO NASDAQ Health Care Biopharmaceuticals USD 1.29 - -80.9% 99%   0% -84%
Agenus Inc. AGEN NASDAQ Health Care Biopharmaceuticals USD 3.04 417 M 54.3% 68%   3% -42%
Agios Pharmaceuticals AGIO NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 37.74 2.2 B -48.6% 56%   1% -57%
Aimmune Therapeutics AIMT NASDAQ Health Care Biopharmaceuticals USD 24.67 1.5 B -11.9% 55%   1% -44%
Akebia Therapeutics, Inc. AKBA NASDAQ Health Care Clinical trial work USD 5.10 606 M -34.6% 70%   1% -61%
Alder BioPharmaceuticals ALDR NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 10.06 841 M -44.7% 61%   1% -53%
Alnylam Pharmaceuticals ALNY NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 83.69 9.3 B -13.8% 49%   1% -35%
Amicus Therapeutics Inc. FOLD NASDAQ Health Care Drug Manufacturers - Diversified USD 9.80 2.5 B -16.5% 54%   1% -36%
AnaptysBio ANAB NASDAQ Health Care Biopharmaceuticals USD 44.12 1.2 B -48.8% 57%   1% -62%
Ardelyx ARDX NASDAQ Health Care Biopharmaceuticals USD 5.31 333 M 39.7% 92%   2% -63%
Arena Pharmaceuticals ARNA NASDAQ Health Care Cannabinoid Therapeutics USD 51.22 2.6 B 21.4% 50%   2% -32%
Array BioPharma ARRY NASDAQ Health Care Biopharmaceuticals USD 47.85 11 B 245.5% 66%   6% -16%
Assembly Biosciences ASMB NASDAQ Health Care Biopharmaceuticals USD 11.35 292 M -67.1% 67%   0% -71%
Atara Biotherapeutics ATRA NASDAQ Health Care Biopharmaceuticals USD 15.16 815 M -63.1% 69%   1% -72%
Athenex ATNX NASDAQ Health Care Drug Manufacturers - Diversified USD 13.78 1.1 B -16.5% 63%   1% -44%
Audentes Therapeutics BOLD NASDAQ Health Care Biopharmaceuticals USD 31.74 1.4 B -19.2% 60%   1% -54%
AVEO Pharmaceuticals Inc. AVEO NASDAQ Health Care Clinical trial work USD 0.94 151 M -65.0% 145%   0% -85%
Axovant Sciences AXGT NASDAQ Health Care Clinical trial work USD 7.69 175 M -53.3% 88%   1% -81%
BeiGene, Ltd BGNE NASDAQ Health Care Gene Editing - Cell Therapies USD 134.19 8.1 B -17.0% 53%   1% -39%
Bellicum Pharmaceuticals BLCM NASDAQ Health Care Biopharmaceuticals USD 1.19 55 M -81.2% 76%   0% -86%
BioCryst Pharmaceuticals BCRX NASDAQ Health Care Biopharmaceuticals USD 3.08 340 M -56.3% 95%   1% -74%
bluebird bio, Inc. BLUE NASDAQ Health Care Biopharmaceuticals USD 104.85 5.8 B -28.2% 53%   1% -40%
Blueprint Medicines Corp BPMC NASDAQ Health Care Biopharmaceuticals USD 78.94 3.9 B 6.7% 56%   2% -42%
Calithera Biosciences CALA NASDAQ Health Care Biopharmaceuticals USD 4.19 225 M -10.4% 61%   1% -47%
Cara Therapeutics CARA NASDAQ Health Care Cannabinoid Therapeutics USD 23.30 1.1 B 6.9% 54%   2% -48%
Celldex Therapeutics CLDX NASDAQ Health Care Immunotherapy USD 2.39 36 M -62.1% 95%   1% -80%
Corbus Pharmaceuticals Holdings CRBP NASDAQ Health Care Cannabinoid Therapeutics USD 5.74 371 M 16.0% 76%   2% -43%
Cymabay Therapeutics CBAY NASDAQ Health Care Clinical trial work USD 5.75 395 M -53.3% 85%   1% -60%
Cytokinetics Inc. CYTK NASDAQ Health Care Biopharmaceuticals USD 12.39 727 M 47.9% 64%   3% -40%
CytomX Therapeutics CTMX NASDAQ Health Care Biopharmaceuticals USD 9.02 410 M -52.1% 73%   1% -57%
Dova Pharmaceuticals DOVA NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 16.02 461 M -33.9% 92%   1% -77%
Epizyme, Inc. EPZM NASDAQ Health Care Biopharmaceuticals USD 11.96 1.1 B 17.8% 67%   2% -51%
Esperion Therapeutics ESPR NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 36.56 993 M -23.8% 58%   1% -42%
FibroGen FGEN NASDAQ Health Care Biopharmaceuticals USD 41.49 3.6 B -30.6% 54%   1% -43%
Five Prime Therapeutics FPRX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 5.72 210 M -57.7% 61%   1% -65%
G1 Therapeutics GTHX NASDAQ Health Care Biopharmaceuticals USD 38.24 1.4 B -43.6% 97%   1% -79%
Geron GERN NASDAQ Health Care Drug Manufacturers - Diversified USD 1.59 300 M -70.9% 123%   0% -85%
Global Blood Therapeutics GBT NASDAQ Health Care Biopharmaceuticals USD 54.04 3.2 B 28.5% 64%   2% -28%
GlycoMimetics GLYC NASDAQ Health Care Clinical trial work USD 4.62 200 M -66.7% 132%   1% -81%
Idera Pharmaceuticals IDRA NASDAQ Health Care Biopharmaceuticals USD 3.17 91 M -61.7% 104%   1% -78%
Immunogen IMGN NASDAQ Health Care Biopharmaceuticals USD 3.17 475 M -64.2% 106%   1% -81%
Immunomedics, Inc. IMMU NASDAQ Health Care Biopharmaceuticals USD 16.72 3.2 B -24.9% 69%   1% -51%
Inovio Pharmaceuticals INO NASDAQ Health Care Biopharmaceuticals USD 2.59 256 M -48.7% 63%   1% -66%
Insmed INSM NASDAQ Health Care Biopharmaceuticals USD 18.82 1.7 B -1.5% 74%   2% -52%
Intra-Cellular Therapies, Inc. ITCI NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 9.94 548 M -55.2% 72%   1% -65%
Iovance Biotherapeutics IOVA NASDAQ Health Care Biopharmaceuticals USD 21.44 2.7 B 60.0% 75%   3% -25%
Jounce Therapeutics JNCE NASDAQ Health Care Immunotherapy USD 3.52 116 M -48.8% 80%   1% -61%
Karyopharm Therapeutics Inc. KPTI NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 11.03 683 M -41.1% 94%   1% -78%
Kura Oncology KURA NASDAQ Health Care Biopharmaceuticals USD 16.03 725 M -5.7% 54%   1% -39%
La Jolla Pharmaceutical LJPC NASDAQ Health Care Biopharmaceuticals USD 10.92 296 M -47.0% 118%   1% -76%
MacroGenics MGNX NASDAQ Health Care Biopharmaceuticals USD 13.08 640 M -44.0% 101%   1% -49%
Madrigal Pharmaceuticals MDGL NASDAQ Health Care Biopharmaceuticals USD 94.71 1.5 B -58.1% 65%   1% -63%
Marinus Pharmaceuticals MRNS NASDAQ Health Care Clinical trial work USD 1.69 89 M -75.3% 150%   0% -90%
Melinta Therapeutics MLNT NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 2.94 40 M -86.2% 176%   0% -93%
Mirati Therapeutics, Inc. MRTX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 85.55 3.4 B 54.7% 67%   3% -27%
MyoKardia MYOK NASDAQ Health Care Biopharmaceuticals USD 53.97 2.5 B -11.4% 49%   1% -41%
NewLink Genetics NLNK NASDAQ Health Care Biopharmaceuticals USD 1.87 477 M -20.8% 66%   1% -47%
Novavax NVAX NASDAQ Health Care Biopharmaceuticals USD 6.32 151 M -77.7% 141%   0% -92%
Paratek Pharmaceuticals PRTK NASDAQ Health Care Biopharmaceuticals USD 5.76 187 M -38.4% 70%   1% -73%
Pieris Pharmaceuticals PIRS NASDAQ Health Care Biopharmaceuticals USD 5.42 268 M 8.6% 68%   2% -57%
Prothena Corp plc PRTA NASDAQ Health Care Biopharmaceuticals USD 8.42 336 M -37.1% 57%   1% -52%
PTC Therapeutics PTCT NASDAQ Health Care Biopharmaceuticals USD 42.86 2.5 B -10.3% 49%   1% -41%
Reata Pharmaceuticals RETA NASDAQ Health Care Biopharmaceuticals USD 86.59 2.6 B -5.9% 58%   2% -47%
REGENXBIO RGNX NASDAQ Health Care Gene Editing - Cell Therapies USD 37.92 1.4 B -53.3% 65%   1% -61%
Rigel Pharmaceuticals RIGL NASDAQ Health Care Biopharmaceuticals USD 1.65 277 M -48.6% 56%   1% -55%
SAGE Therapeutics SAGE NASDAQ Health Care Biopharmaceuticals USD 159.79 8.3 B 7.7% 61%   2% -45%
Sangamo Therapeutics SGMO NASDAQ Health Care Gene Editing - Cell Therapies USD 10.85 1.3 B -26.9% 79%   2% -54%
Seres Therapeutics MCRB NASDAQ Health Care Biopharmaceuticals USD 3.79 265 M -51.5% 82%   1% -74%
Stemline Therapeutics STML NASDAQ Health Care Biopharmaceuticals USD 10.79 474 M -36.5% 65%   1% -53%
Tetraphase Pharmaceuticals TTPH NASDAQ Health Care Drug Manufacturers - Diversified USD 0.38 20 M -87.7% 81%   0% -93%
TG Therapeutics TGTX NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 6.47 613 M -39.8% 89%   1% -68%
Ultragenyx Pharmaceutical Inc. RARE NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 44.10 2.5 B -49.2% 58%   1% -57%
uniQure QURE NASDAQ Health Care Gene Editing - Cell Therapies USD 47.48 1.8 B 15.0% 73%   2% -46%
Voyager Therapeutics VYGR NASDAQ Health Care Biopharmaceuticals USD 17.19 635 M -12.0% 71%   2% -42%
Xencor XNCR NASDAQ Health Care Clinical trial work USD 35.38 2.0 B -25.8% 57%   1% -42%
ZIOPHARM Oncology ZIOP NASDAQ Health Care Biopharmaceuticals USD 4.73 769 M 73.9% 78%   3% -35%